Literature DB >> 3975967

Prognosis in middle cerebral artery occlusion.

D E Moulin, R Lo, J Chiang, H J Barnett.   

Abstract

The natural history of MCA occlusion has become increasingly important since the surgical option of EC/IC bypass surgery has been available. The clinical course of 24 patients with angiographically-demonstrated occlusion of the MCA artery was reviewed. Eight patients presented with a major disabling stroke and five of these died during the acute phase of this ischemic event. The remaining 19 patients were followed for a mean of 54.2 months. There were five deaths in follow-up and two of these were due to subsequent strokes. Fourteen patients manifested a benign course: one of these had a further minor stroke and four had TIAs. Altogether, 3 strokes occurred during the follow-up period (2 fatal, 1 minor) and all were in the territory of the artery known to be occluded. Of those patients who survived their presenting ischemic event, 12 (63%) remained completely functional in terms of activities of daily living. MCA occlusion does not necessarily carry a poor prognosis with medial therapy alone and the role of bypass surgery hopefully will be clarified by the ongoing clinically randomized trial.

Entities:  

Mesh:

Year:  1985        PMID: 3975967     DOI: 10.1161/01.str.16.2.282

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  24 in total

1.  Intraarterial Thrombolysis with r-tPA for Treatment of Anterior Circulation Acute Ischemic Stroke. Technical and Clinical Results.

Authors:  F Baltacioğlu; N Afşar; G Ekinci; N Tuncer-Elmaci; N Cagatay Cimşit; S Aktan; C Erzen
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

2.  Decompressive surgery in malignant infarction of the middle cerebral artery.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

3.  Treatment of malignant brain edema and increased intracranial pressure after stroke.

Authors:  Michael E Brogan; Edward M Manno
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

4.  Decompressive craniectomy in neurocritical care.

Authors:  Stacy Y Chu; Kevin N Sheth
Journal:  Curr Treat Options Neurol       Date:  2015-02       Impact factor: 3.598

5.  The "dense artery sign"--major cerebral artery thromboembolism demonstrated by computed tomography.

Authors:  B Schuknecht; M Ratzka; E Hofmann
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

6.  Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury.

Authors:  Matthew Campbell; Finnian Hanrahan; Oliviero L Gobbo; Michael E Kelly; Anna-Sophia Kiang; Marian M Humphries; Anh T H Nguyen; Ema Ozaki; James Keaney; Christoph W Blau; Christian M Kerskens; Stephen D Cahalan; John J Callanan; Eugene Wallace; Gerald A Grant; Colin P Doherty; Peter Humphries
Journal:  Nat Commun       Date:  2012-05-22       Impact factor: 14.919

7.  Intracranial balloon angioplasty of acute terminal internal carotid artery occlusions.

Authors:  Joon K Song; Edwin D Cacayorin; Morgan S Campbell; Stanley Fisher; Marc D Malkoff; Andrei V Alexandrov; James C Grotta
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

8.  Asymptomatic middle cerebral artery stenosis diagnosed by magnetic resonance angiography.

Authors:  O O Zaidat; D B Zahuranec; E E Ubogu; J A Fernandes-Filho; J I Suárez; J L Sunshine; R W Tarr; S Mirarchi; S G Nour; W R Selman; D M D Landis
Journal:  Neuroradiology       Date:  2003-12-04       Impact factor: 2.804

9.  Surgical management of massive cerebral infarction.

Authors:  Jun Suk Huh; Hyung Shik Shin; Jun Jae Shin; Tae Hong Kim; Yong Soon Hwang; Sang Keun Park
Journal:  J Korean Neurosurg Soc       Date:  2007-10-20

10.  Surgical treatment for acute, severe brain infarction.

Authors:  Je-On Park; Dong-Hyuk Park; Sang-Dae Kim; Dong-Jun Lim; Jung-Yul Park
Journal:  J Korean Neurosurg Soc       Date:  2007-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.